- Home
- CWCO vs VERV Comparison
CWCO vs VERV Comparison
Compare CWCO & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWCO
- VERV
- Stock Information
- Founded
- CWCO 1973
- VERV 2018
- Country
- CWCO Cayman Islands
- VERV United States
- Employees
- CWCO N/A
- VERV N/A
- Industry
- CWCO Water Supply
- VERV Medicinal Chemicals and Botanical Products
- Sector
- CWCO Utilities
- VERV Health Care
- Exchange
- CWCO Nasdaq
- VERV Nasdaq
- Market Cap
- CWCO 402.4M
- VERV 384.2M
- IPO Year
- CWCO N/A
- VERV 2021
- Fundamental
- Price
- CWCO $30.83
- VERV $11.16
- Analyst Decision
- CWCO
- VERV Buy
- Analyst Count
- CWCO 0
- VERV 10
- Target Price
- CWCO N/A
- VERV $14.57
- AVG Volume (30 Days)
- CWCO 171.9K
- VERV 7.8M
- Earning Date
- CWCO 08-13-2025
- VERV 08-07-2025
- Dividend Yield
- CWCO 1.83%
- VERV N/A
- EPS Growth
- CWCO N/A
- VERV N/A
- EPS
- CWCO 1.67
- VERV N/A
- Revenue
- CWCO $127,992,628.00
- VERV $59,613,000.00
- Revenue This Year
- CWCO $2.26
- VERV $27.75
- Revenue Next Year
- CWCO $57.33
- VERV N/A
- P/E Ratio
- CWCO $18.27
- VERV N/A
- Revenue Growth
- CWCO N/A
- VERV 271.44
- 52 Week Low
- CWCO $22.69
- VERV $2.87
- 52 Week High
- CWCO $31.30
- VERV $11.41
- Technical
- Relative Strength Index (RSI)
- CWCO 66.45
- VERV 80.59
- Support Level
- CWCO $29.70
- VERV $11.16
- Resistance Level
- CWCO $31.30
- VERV $11.34
- Average True Range (ATR)
- CWCO 0.82
- VERV 0.18
- MACD
- CWCO 0.05
- VERV -0.00
- Stochastic Oscillator
- CWCO 78.36
- VERV 95.52
About CWCO Consolidated Water Co. Ltd.
Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties, and The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal and industrial water production, supply and treatment.
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.